---
title: A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial
  of adjunctive N-Acetylcysteine for treatment-resistant PTSD
date: '2023-08-04'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37540942/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230805180723&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: This was the first multicentre, double-blind, randomised,
  placebo-controlled trial of adjunctive NAC for treatment-resistant PTSD. No benefit
  of NAC was observed in this group beyond that provided by placebo at end of the
  ...'
disable_comments: true
---
CONCLUSION: This was the first multicentre, double-blind, randomised, placebo-controlled trial of adjunctive NAC for treatment-resistant PTSD. No benefit of NAC was observed in this group beyond that provided by placebo at end of the ...